| # | Drug | Count |
|---|---|---|
| 0 | GABAPENTIN | 26 |
| 1 | LEVOTHYROXINE SODIUM | 22 |
| 2 | PEMBROLIZUMAB | 21 |
| 3 | NAPROXEN SODIUM | 20 |
| 4 | NAPROXEN | 18 |
| 5 | ACETAMINOPHEN | 15 |
| 6 | CARBOPLATIN | 14 |
| 7 | ONDANSETRON HYDROCHLORIDE | 14 |
| 8 | ERGOCALCIFEROL | 13 |
| 9 | METFORMIN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | XEROPHYLLUM ASPHODELOIDES, ACONITUM NAP., ANACARDIUM ORIENTALE, APIS MEL., BRYONIA, CANTHARIS, CROTON, GRAPHITES, GRINDELIA, MEZEREUM, NUX VOM., RANUNC. BULB., RHUS TOXICODENDRON, SARSAPARILLA, SULPHUR, ECHINACEA, RUMEX CRISP.,TARAXACUM, URTICA UR. | 1 | 0.0250 |
| 1 | CALCIUM ANTACID | 1 | 0.0023 |
| 2 | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0016 |
| 3 | PSYLLIUM HUSK | 2 | 0.0015 |
| 4 | QUIZARTINIB | 1 | 0.0014 |
| 5 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 6 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 7 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 8 | AMIFOSTINE | 1 | 0.0012 |
| 9 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 2 | Platinum-based Drug [EPC] | 26 |
| 3 | Corticosteroid [EPC] | 24 |
| 4 | Kinase Inhibitor [EPC] | 21 |
| 5 | Aromatase Inhibitor [EPC] | 16 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 7 | Opioid Agonist [EPC] | 14 |
| 8 | Serotonin-3 Receptor Antagonist [EPC] | 14 |
| 9 | Provitamin D2 Compound [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Monobactam Antibacterial [EPC] | 3 | 0.0011 |
| 1 | Calcitonin [EPC] | 2 | 0.0006 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 | 0.0004 |
| 5 | Prostaglandin E1 Analog [EPC] | 5 | 0.0003 |
| 6 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |
| 7 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 6 | 0.0002 |
| 8 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 9 | 0.0002 |